CHEPLAPHARM Digitalizes Supply Chain with TraceLink
Analysis based on 6 articles · First reported May 14, 2026 · Last updated May 14, 2026
The partnership between Cheplapharm Arzneimittel and TraceLink is expected to enhance efficiency and resilience in the pharmaceutical supply chain, potentially leading to improved stock performance for companies in the software and pharmaceutical sectors that adopt similar digitalization strategies. This move by Cheplapharm Arzneimittel could encourage other pharmaceutical companies to invest in advanced supply chain solutions, benefiting software providers like TraceLink.
Cheplapharm Arzneimittel, a German pharmaceutical company, has gone live on the TraceLink network with its Multienterprise Information Network Tower (MINT) platform. This implementation aims to digitalize and automate Cheplapharm Arzneimittel's global supply chain operations, which had previously relied on manual processes. The move is expected to reduce administrative workload, improve transparency, and enable more efficient and scalable operations with its partners. Luise Daberkow of Cheplapharm Arzneimittel emphasized the need to eliminate manual workflows, while Shabbir Dahod of TraceLink highlighted the forward-looking approach to supply chain intelligence. The partnership leverages TraceLink's Integrate-Once model, allowing rapid and cost-free partner onboarding, and is seen as a foundation for future AI-driven supply chain orchestration.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard